Trial Profile
A study to evaluate the contrasting effects of sitagliptin and exenatide on plasma concentrations of betatrophin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Exenatide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Dec 2015 New trial record